These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4712591)

  • 1. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid cells derived from fusion of TA3-Ha ascites carcinoma with normal fibroblasts. 1. Malignancy, karyotype, and formation of isoantigenic variants.
    Klein G; Friberg S; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1259-68. PubMed ID: 4712590
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells.
    Wiener F; Dalianis T; Klein G; Harris H
    J Natl Cancer Inst; 1974 Jun; 52(6):1779-96. PubMed ID: 4834408
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma.
    Klein G
    J Natl Cancer Inst; 1977 Feb; 58(2):383-6. PubMed ID: 833884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 6. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 7. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
    Klein G; Friberg S; Harris H
    J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-host cell hybrids in radiochimeras.
    Wiener F; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):148-52. PubMed ID: 4521047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic characteristics of murine leukemia induced by chemical carcinogens.
    Colnaghi MI; Della Porta G
    Bibl Haematol; 1973; 39():595-602. PubMed ID: 4591438
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro.
    Kieler J; Radzikowski C; Moore J; Ulrich K
    J Natl Cancer Inst; 1972 Feb; 48(2):393-405. PubMed ID: 4652381
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies of cellular-mediated immunostimulation of tumor growth.
    Fidler IJ
    J Natl Cancer Inst; 1973 May; 50(5):1307-12. PubMed ID: 4712593
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal influence on responsiveness of multiparous mice to the antigenic characteristics of their male progeny.
    Uphoff DE
    J Natl Cancer Inst; 1974 Jun; 52(6):1843-7. PubMed ID: 4599649
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface antigen expression in malignant sublines derived from hybrid cells of low malignancy.
    Grundner G; Fenyö EM; Klein E; Bregula U; Harris H
    Exp Cell Res; 1971 Oct; 68(2):315-22. PubMed ID: 4108039
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier.
    Bevan MJ
    Nature; 1975 Jul; 256(5516):419-21. PubMed ID: 1079924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.